JG
MNTA

Jefferies Group’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Jefferies Group’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-13,227
Closed -$245K – 2942
2017
Q3 		$245K Buy
+13,227
New +$221K ﹤0.01% 1981
2017
Q2 		– Sell
-18,471
Closed -$247K – 2733
2017
Q1 		$247K Buy
+18,471
New +$289K ﹤0.01% 1922
2014
Q3 		– Sell
-132
Closed -$2K – 2564
2014
Q2 		$2K Sell
132
-16,618
-99% -$196K ﹤0.01% 2019
2014
Q1 		$195K Sell
16,750
-30,400
-64% -$515K ﹤0.01% 1745
2013
Q4 		$834K Buy
+47,150
New +$792K 0.01% 912

Jefferies Group's MNTA Position: Q4 2017 in Review

Jefferies Group sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2017, closing a stake of 13,227 shares — an estimated $245K sold.

Jefferies Group first reported a position in MNTA in Q4 2013 and held it in 5 quarters. The position peaked at $834K in Q4 2013. 166 funds tracked by Wall St. Rank hold MNTA as of Q4 2017.

  • Jefferies Group reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2017 after selling out during the quarter.
  • Jefferies Group sold 13,227 Momenta Pharmaceuticals, Inc. shares in Q4 2017, an estimated $245K.
  • Jefferies Group first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2013 and held it in 5 quarters.
  • Jefferies Group's Momenta Pharmaceuticals, Inc. position peaked at $834K in Q4 2013.
  • 166 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2017.

Based on Jefferies Group's 13F filing for Q4 2017, filed 14 Feb 2018.